Table 4 Adverse events during the 52-week period
Adverse events | Number of affected participants (%) |
|---|---|
New-onset dyspepsia and heartburn | 4 (5.00%) |
Back pain | 3 (3.75%) |
Pyrexia with myalgia | 2 (2.50%) |
Nausea | 1 (1.25%) |
Diarrhoea | 1 (1.25%) |
Adverse events | Number of affected participants (%) |
|---|---|
New-onset dyspepsia and heartburn | 4 (5.00%) |
Back pain | 3 (3.75%) |
Pyrexia with myalgia | 2 (2.50%) |
Nausea | 1 (1.25%) |
Diarrhoea | 1 (1.25%) |